International Pharmacovigilance Training course
UMC’s distinctive course, established in 1993, welcomes around 30 participants to Uppsala, in May each year. International Pharmacovigilance Training course
Uppsala Monitoring Centre will hold its 20th international pharmacovigilance training course in Uppsala, Sweden, on 21 May to 1 June 2018.
About Uppsala Monitoring Centre:
Uppsala Monitoring Centre (UMC) advances the science of pharmacovigilance and inspires patient safety initiatives all over the world. As an independent, non-profit foundation, UMC engages stakeholders who share their vision and collaborates to build a global patient safety culture. As a leader in the research and development of new scientific methods, UMC explores the benefits and risks of medicines to help minimize harm to patients and offers products and services used by health authorities and life-science companies worldwide. For almost 40 years, UMC has provided scientific leadership and operational support to the WHO Programme for International Drug Monitoring.
Participants study topics essential to effective pharmacovigilance, among them pharmacovigilance best practices, pharmacovigilance tools, signal detection, causality assessment and communications.
Also Read: Pharmacovigilance Books Info
This course is tailored for representatives of national pharmacovigilance centers and ministries of health but is also suitable for representatives of public health programmes and healthcare professionals from hospitals or academic settings.
You will find more information in the course brochure below.
The course focuses on topics essential to effective pharmacovigilance, including sessions to strengthen the WHO Programme for International Drug Monitoring, e.g. pharmacovigilance best practices, communications, creating a reporting culture and pharmacovigilance tools. The course agenda also includes extensive workshops in hands-on signal detection and causality assessment as well as vaccine safety and pharmacoepidemiology.
Training, built around lectures, workshops, and practical exercises, takes place in an open and interactive environment. Plenty of opportunities to interact with UMC staff, faculty experts and fellow course participants will be provided. Social
activities and events include an official course dinner and ‘open house’ at the UMC office.
Faculty: International pharmacovigilance experts from the WHO Headquarters, WHO Collaborating Centres, UMC, and other well-known organizations will lead the sessions.
Interested: This two-week course is tailored for representatives of national pharmacovigilance centres and ministries of health but is also suitable for representatives of public health programmes and healthcare professionals, (e.g.
physicians, pharmacists, nurses) from hospitals or academic settings. Participants are expected to actively contribute to discussions in English and have experience in the pharmacovigilance field.
How to apply: The goal of UMC’s admissions review process is to select individuals committed to patient safety who can contribute actively during these two weeks. All participants will be given access to pre-course reading materials.
We encourage you to start the application process as soon as possible; the course is designed for a maximum of 30 people.
Please submit your application via the electronic form available on the UMC website (www.who-umc.org) by January 12th, 2018.
If you have questions, please visit UMC website: www.who-umc.org
or contact the course management via e-mail: email@example.com
Source & Reference: WHO-UMC Official Site
Please submit your application via the electronic form available here by 12th January 2018.